These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38423469)

  • 21. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
    de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
    Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Causative Drugs of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Israel.
    Maggio N; Firer M; Zaid H; Bederovsky Y; Aboukaoud M; Gandelman-Marton R; Noyman I; Ekstein D; Blatt I; Marom E; Schwartzberg E; Israel S; Ingber A; Brautbar C; Eyal S
    J Clin Pharmacol; 2017 Jul; 57(7):823-829. PubMed ID: 28181259
    [No Abstract]   [Full Text] [Related]  

  • 23. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19-induced toxic epidermal necrolysis.
    Narang I; Panthagani AP; Lewis M; Chohan B; Ferguson A; Nambi R
    Clin Exp Dermatol; 2021 Jul; 46(5):927-929. PubMed ID: 33511662
    [No Abstract]   [Full Text] [Related]  

  • 25. Ocular manifestation, complications and aetiological factors in Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Chhipa SA; Masood S; Salarzai Y; Khan QA; Ahmad K; Sajid S
    J Pak Med Assoc; 2015 Jan; 65(1):62-4. PubMed ID: 25831677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term sequelae from Stevens-Johnson syndrome/toxic epidermal necrolysis in a large retrospective cohort.
    Wang LL; Noe MH; Micheletti RG
    J Am Acad Dermatol; 2021 Mar; 84(3):784-786. PubMed ID: 32289398
    [No Abstract]   [Full Text] [Related]  

  • 27. Aetiology in sixteen cases of toxic epidermal necrolysis and Stevens-Johnson syndrome admitted within eight months in a teaching hospital.
    Yeung CK; Ma SY; Hon C; Peiris M; Chan HH
    Acta Derm Venereol; 2003; 83(3):179-82. PubMed ID: 12816151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stevens-Johnson syndrome and toxic epidermal necrolysis from pathologist's point of view.
    Sticová E; Kyclová J; Důra M; Štork J; Lipový B
    Cesk Patol; 2023; 59(3):124-128. PubMed ID: 37805268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent blisters in a case of resolving Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Chuang YN; Ho YY; Chiu TM
    Indian J Dermatol Venereol Leprol; 2014; 80(6):546-7. PubMed ID: 25382518
    [No Abstract]   [Full Text] [Related]  

  • 33. Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of six cases.
    Kara A; Devrim İ; Çağlar İ; Bayram N; Kundak S; Apa H; Altan EV
    Turk J Pediatr; 2019; 61(4):538-543. PubMed ID: 31990471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D; From L; Ricciatti D; Shapero H
    Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute blistering diseases on the burn ward: Beyond Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Richer V; Bouffard D; Bélisle A; Duranceau L; Perreault I; Provost N
    Burns; 2013 Sep; 39(6):1290-6. PubMed ID: 23597847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxic epidermal necrolysis and Stevens-Johnson syndrome after COVID-19 infection and vaccination.
    Zou H; Daveluy S
    Australas J Dermatol; 2023 Feb; 64(1):e1-e10. PubMed ID: 36484649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulfasalazine-Induced Toxic Epidermal Necrolysis: A Challenging Case During the COVID-19 Pandemic.
    Shahidi-Dadras M; Shahrigharahkoshan S; Yazdi E; Fatemi A; Mahboubi-Fooladi Z; Dadkhahfar S
    Adv Emerg Nurs J; 2021 Jul-Sep 01; 43(3):194-197. PubMed ID: 34397495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
    Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
    Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiological and clinical outcomes analysis in public hospitals.
    Arantes LB; Reis CS; Novaes AG; Carvalho MR; Göttems LBD; Novaes MRCG
    An Bras Dermatol; 2017; 92(5):661-667. PubMed ID: 29166503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal replacement therapy during Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective observational study of 238 patients.
    Papo M; Valeyrie-Allanore L; Razazi K; Carteaux G; Wolkenstein P; Chosidow O; Brun-Buisson C; Mekontso Dessap A; de Prost N
    Br J Dermatol; 2017 May; 176(5):1370-1372. PubMed ID: 27510226
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.